+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lidocaine Hydrochloride Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4997490
  • Report
  • March 2020
  • Region: Global
  • 122 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Alanza Inc
  • Cirondrugs
  • MAHENDRA CHEMICALS
  • Medexim India
  • Merck KGaA
  • Nortec Qumica
  • MORE
The global lidocaine hydrochloride market size is expected to grow at a CAGR of 4.1% during the forecast period. Increase in number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries are expected to promote growth. Global rise in chronic and acute pain related disorders and various benefits associated with lidocaine hydrochloride are some of the major factors driving the market growth.

A key trend observed in the market is a significant rise in demand for post-operative pain relief options, on the heels of increasing number of surgical procedures. This trend is likely to continue positively influencing the demand for lidocaine hydrochloride. As per the study of “Postoperative Pain Control”, around 75 percent of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity which further bolster the overall growth.

Also, lidocaine patches are available for the treatment of chronic and acute pain. Owing to their safety profile and proven efficacy, lidocaine patches have been recommended as a first-line therapy for the treatment of neuropathic pain in older patients as well as those suffering from shingles, and this is expected to boost market growth during the forecast period. However, side effects such as idiosyncrasy & hypersensitivity may restrict the market.

Key Market Trends

The Dental Procedure Dominates the Market and is Expected to Continue the Same during the Forecast Period
  • Dental Procedure segment is expected to grow at a lucrative CAGR during the forecast period. This is primarily attributed to extensive usage of lidocaine hydrochloride injectable in different surgical dental procedures. Increase in prevalence of dental disorders coupled with growing number of surgeries performed is the key driving factor for this segment.
  • Chronic and acute pain associated with dental procedure is the most common reason for visits to healthcare facilities, which makes it the foremost cause of discomfort in patients, thereby contributing largely to healthcare costs. The aforementioned factors bode a well for the segmental growth.
The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America is leading owing to the presence of major market players. Increasing incidence of pain and pain-related disorders coupled with the escalating prevalence of epilepsy and dental procedures in the U.S. are among factors driving the market in this region. This has been adding to healthcare expenditures of the nations in the region. Incremental rise in the number of patients and increasing product cognizance & adoption has also been accelerating market growth in the region.

The Asia-Pacific is expected to witness the fastest growth over the forecast period. The growth is attributed to increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of lidocaine hydrochloride in post-operative pain management. Moreover, expanding geriatric population, is anticipated to drive the number of surgical procedures performed in the region, thereby promising growth over the forecast period.

Competitive Landscape

The lidocaine hydrochloride market is consolidated and consists of selective number of major players. Some of the key players include companies such Alanza Inc, Amphastar Pharmaceuticals, Inc., Cirondrugs, MAHENDRA CHEMICALS, Medexim India, Merck KGaA, Nortec Qumica, Pfizer Inc. Investment for the development of effective & long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market share.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alanza Inc
  • Cirondrugs
  • MAHENDRA CHEMICALS
  • Medexim India
  • Merck KGaA
  • Nortec Qumica
  • MORE
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Prevalence of Target Disease
4.2.2 Rising Demand For Anesthetics in Surgeries
4.3 Market Restraints
4.3.1 Risk Associated with Lidocaine Hydrochloride
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Dosage Form
5.1.1 Creams
5.1.2 Patches
5.1.3 Injectables
5.1.4 Others
5.2 By Application
5.2.1 Heart Arrhythmia
5.2.2 Dental Procedure
5.2.3 Epilepsy
5.2.4 Other
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alanza Inc
6.1.2 Amphastar Pharmaceuticals, Inc.
6.1.3 Cirondrugs
6.1.4 MAHENDRA CHEMICALS
6.1.5 Medexim India
6.1.6 Merck KGaA
6.1.7 Nortec Qumica
6.1.8 Pfizer Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alanza Inc
  • Amphastar Pharmaceuticals, Inc.
  • Cirondrugs
  • MAHENDRA CHEMICALS
  • Medexim India
  • Merck KGaA
  • Nortec Qumica
  • Pfizer Inc
Note: Product cover images may vary from those shown
Adroll
adroll